Growth hormone deficiency epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 7: Line 7:
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*incidence rate of 1 case per 3,500 children.   approximately 25% of the patients with growth hormone deficiency had an organic  Mortality in children with growth hormone (GH) deficiency is due almost entirely to other pituitary hormone deficiencies. <sup>[[null 1]]</sup>  These children have an increased relative risk of death in adulthood from cardiovascular causes resulting from altered body composition and dyslipidemia  === Sex === The sex distribution of patients with idiopathic growth hormone deficiency is 73% male and 27% female. <sup>[[null 4], [null 5], [null 6]]</sup>  Cuttler et al published results of a survey of pediatric endocrinologists that growth hormone treatment was 1.3 times more common in boys than in girls. <sup>[[null 10]]</sup> === Age === Diagnosis of growth hormone deficiency is made during 2 broad age peaks. The first age peak occurs at 5 years, a time when children begin school  The second age peak occurs in girls aged 10-13 years and boys aged 12-16 years.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 
===Case-fatality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.
*The case-fatality rate of [disease name] is approximately [number range].
===Age===
*Patients of all age groups may develop [disease name].
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].
 
===Race===
*There is no racial predilection to [disease name].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
*[Disease name] affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===
 
 


==References==
==References==

Revision as of 19:07, 11 August 2017

Growth hormone deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Growth hormone deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Growth hormone deficiency epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Growth hormone deficiency epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Growth hormone deficiency epidemiology and demographics

CDC on Growth hormone deficiency epidemiology and demographics

Growth hormone deficiency epidemiology and demographics in the news

Blogs on Growth hormone deficiency epidemiology and demographics

Directions to Hospitals Treating Growth hormone deficiency

Risk calculators and risk factors for Growth hormone deficiency epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Epidemiology and Demographics

Incidence

  • incidence rate of 1 case per 3,500 children. approximately 25% of the patients with growth hormone deficiency had an organic Mortality in children with growth hormone (GH) deficiency is due almost entirely to other pituitary hormone deficiencies. null 1 These children have an increased relative risk of death in adulthood from cardiovascular causes resulting from altered body composition and dyslipidemia === Sex === The sex distribution of patients with idiopathic growth hormone deficiency is 73% male and 27% female. [[null 4], [null 5], [null 6]] Cuttler et al published results of a survey of pediatric endocrinologists that growth hormone treatment was 1.3 times more common in boys than in girls. null 10 === Age === Diagnosis of growth hormone deficiency is made during 2 broad age peaks. The first age peak occurs at 5 years, a time when children begin school The second age peak occurs in girls aged 10-13 years and boys aged 12-16 years.

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Growth_hormone_deficiency_epidemiology_and_demographics&oldid=1340043"